Loading...
OTCM
VASO
Market cap51mUSD
Oct 08, Last price  
0.29USD
1D
-0.64%
1Q
46.79%
Jan 2017
132.54%
Name

Vaso Corp

Chart & performance

D1W1MN
OTCM:VASO chart
P/E
32.87
P/S
0.58
EPS
0.01
Div yield, %
—
Shrs. gr., 5y
0.60%
Rev. gr., 5y
4.99%
Revenues
89m
+2.68%
10,942,9976,354,0835,182,7684,471,1864,205,94216,373,42429,240,00032,890,00034,954,00057,082,00072,589,00072,788,00073,980,00075,746,00069,850,00075,579,00080,017,00081,024,00086,767,00089,096,000
Net income
2m
+64.98%
-10,701,141-1,571,066-676,965-1,524,711-1,892,073-3,890,529-3,381,000-1,145,0001,128,0003,823,000820,000-4,539,000-3,734,00039,000358,0006,100,00011,873,0004,805,000951,0001,569,000
CFO
9m
+182.63%
-2,275,873-1,233,294-32,021-1,716,860-1,588,3874,139,8409,431,000-1,504,0002,594,0006,520,0005,215,0001,599,000-1,453,000-1,333,0005,934,0007,815,00014,416,0005,296,0003,281,0009,273,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vaso Corporation is a diversified enterprise engaged in both the healthcare equipment and information technology industries, serving markets within the United States and globally. The company's operations are structured across three primary divisions: 1. IT (Information Technology): This segment is dedicated to providing specialized IT solutions for the healthcare sector, alongside managed network technology services. Its services encompass managed diagnostic imaging applications, network infrastructure management, network transport, and comprehensive cybersecurity solutions. 2. Professional Sales Service: This division primarily focuses on the distribution of capital medical equipment manufactured by General Electric Healthcare (GEHC) to mid-sized healthcare providers. Its offerings include GEHC diagnostic imaging hardware, associated service contracts, training programs, and financial services facilitated by both GEHC and external partners. 3. Equipment: This segment concentrates on the development, manufacturing, sales, and servicing of its own proprietary medical devices. Its product portfolio features the Biox series, which includes Holter monitors and ambulatory blood pressure recorders; the ARCS series software for analyzing, reporting, and communicating ECG and blood pressure data; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation (EECP) therapy systems, used for non-invasive, outpatient treatment of ischemic heart disease. Founded in 1987, the company was originally named Vasomedical, Inc. before officially rebranding as Vaso Corporation in November 2016. Vaso Corporation maintains its corporate headquarters in Plainview, New York.

Key people

Simon Srybnik
Chairman of Emeritus · since 2016
Michael J. Beecher
Chief Financial Officer, Secretary · since 2011
Peter C. Castle
Chief Operating Officer, Director · since 2015
Jonathan P. Newton
Vice President - Finance, Treasurer · since 2011
David H. Lieberman
Vice Chairman of the Board ,Director · since 2011
Jun Ma
President, Chief Executive Officer, Director · since 2010
Joshua Markowitz
Chairman of the Board · since 2016
Behnam Movaseghi
Independent Director · since 2007
IPO date
Dec 01, 1988
Employees
272
Domiciled in
US
Incorporated in
US
Legal address
C/O The Corporation Trust Company
Corporation Trust Center
1209 Orange Street
Wilmington, DE 19801
US
Headquarters
137 Commercial Street
Unit 200
Plainview, NY 11803
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT